Clinical trial
Amphotericin B Treatment in Visceral Leishmaniasis
NCT00310505 · Banaras Hindu University, Other · Completed
Key facts
| NCT number | NCT00310505 |
|---|---|
| Title | Amphotericin B Treatment in Visceral Leishmaniasis |
| Official title | Randomised Double Blind Dose Ranging Study of Amphotericin B in Visceral Leishmaniasis |
| Lead sponsor | Banaras Hindu University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Visceral Leishmaniasis |
| Intervention type | Drug |
| Interventions | Amphotericin B deoxycholate given as daily administration |
| Enrollment | 1,500 |
| Start date | Jan 1, 2003 |
| First posted | Apr 4, 2006 |
| Last update posted | Sep 12, 2008 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: